Similar articles

• Biochemical markers of bone turnover in diagnosis and assessment of therapy.

  Riis BJ. Riis BJ. Am J Med. 1991 Nov 25;91(5B):64S-68S. doi: 10.1016/0002-9343(91)90251-r. Am J Med. 1991. PMID: 1750422 Review. No abstract available.
• Biological variation of biochemical bone markers.

  Jensen JE, Sørensen HA, Kollerup G, Jensen LB, Sørensen OH. Jensen JE, et al. Scand J Clin Lab Invest Suppl. 1994;219:36-9. doi: 10.3109/00365519409088575. Scand J Clin Lab Invest Suppl. 1994. PMID: 7701238 No abstract available.
• Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.

  Fletcher CD, Farish E, Leggate J, Hart DM. Fletcher CD, et al. Acta Endocrinol (Copenh). 1991 Apr;124(4):353-6. doi: 10.1530/acta.0.1240353. Acta Endocrinol (Copenh). 1991. PMID: 2031433
• Metabolic markers for the early diagnosis of postmenopausal osteoporosis.

  Isaia G, Mussetta M, Di Stefano M, Sciolla A, Triolo S, Molinatti GM. Isaia G, et al. J Endocrinol Invest. 1994 Nov;17(10):771-4. doi: 10.1007/BF03347773. J Endocrinol Invest. 1994. PMID: 7699209
• Biochemical markers of bone turnover: methodology and clinical use in osteoporosis.

  Delmas PD. Delmas PD. Am J Med. 1991 Nov 25;91(5B):59S-63S. doi: 10.1016/0002-9343(91)90250-2. Am J Med. 1991. PMID: 1750421 Review. No abstract available.